Literature DB >> 24390461

A fluorescence-based high throughput assay for the determination of small molecule-human serum albumin protein binding.

Megan M McCallum1, Alan J Pawlak, William R Shadrick, Anton Simeonov, Ajit Jadhav, Adam Yasgar, David J Maloney, Leggy A Arnold.   

Abstract

Herein, we describe the development of a fluorescence-based high throughput assay to determine the small molecule binding towards human serum albumin (HSA). This innovative competition assay is based on the use of a novel fluorescent small molecule Red Mega 500 with unique spectroscopic and binding properties. The commercially available probe displays a large fluorescence intensity difference between the protein-bound and protein-unbound state. The competition of small molecules for HSA binding in the presence of probe resulted in low fluorescence intensities. The assay was evaluated with the library of pharmacological active compounds (LOPAC) small molecule library of 1,280 compounds identifying known high protein binders. The small molecule competition of HSA-Red Mega 500 binding was saturable at higher compound concentrations and exhibited IC50 values between 3 and 24 μM. The compound affinity toward HSA was confirmed by isothermal titration calorimetry indicating that the new protein binding assay is a valid high throughput assay to determine plasma protein binding.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24390461      PMCID: PMC3959589          DOI: 10.1007/s00216-013-7560-3

Source DB:  PubMed          Journal:  Anal Bioanal Chem        ISSN: 1618-2642            Impact factor:   4.142


  26 in total

1.  A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays.

Authors: 
Journal:  J Biomol Screen       Date:  1999

Review 2.  Tyrphostins and other tyrosine kinase inhibitors.

Authors:  Alexander Levitzki; Eyal Mishani
Journal:  Annu Rev Biochem       Date:  2006       Impact factor: 23.643

Review 3.  Biomolecular interaction analysis in drug discovery using surface plasmon resonance technology.

Authors:  Walter Huber; Francis Mueller
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

4.  Plasma protein binding of gyrase inhibitors.

Authors:  G Zlotos; A Bücker; M Kinzig-Schippers; F Sorgel; U Holzgrabe
Journal:  J Pharm Sci       Date:  1998-02       Impact factor: 3.534

5.  A re-evaluation of the HSA-piroxicam interaction.

Authors:  F Brée; S Urien; P Nguyen; P Riant; E Albengres; J P Tillement
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1990 Oct-Dec       Impact factor: 2.441

6.  Subdomain IB is the third major drug binding region of human serum albumin: toward the three-sites model.

Authors:  Ferenc Zsila
Journal:  Mol Pharm       Date:  2013-03-26       Impact factor: 4.939

Review 7.  A thousand points of light: the application of fluorescence detection technologies to two-dimensional gel electrophoresis and proteomics.

Authors:  W F Patton
Journal:  Electrophoresis       Date:  2000-04       Impact factor: 3.535

Review 8.  Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with Gram-positive infections.

Authors:  Alasdair P MacGowan
Journal:  J Antimicrob Chemother       Date:  2003-05       Impact factor: 5.790

Review 9.  Pharmacokinetics and pharmacodynamics of H2-receptor antagonists in patients with renal insufficiency.

Authors:  U Gladziwa; U Klotz
Journal:  Clin Pharmacokinet       Date:  1993-04       Impact factor: 6.447

Review 10.  Stereoselective disposition of proton pump inhibitors.

Authors:  Tommy Andersson; Lars Weidolf
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

View more
  5 in total

1.  Fluorescence polarization assays in high-throughput screening and drug discovery: a review.

Authors:  Matthew D Hall; Adam Yasgar; Tyler Peryea; John C Braisted; Ajit Jadhav; Anton Simeonov; Nathan P Coussens
Journal:  Methods Appl Fluoresc       Date:  2016-04-28       Impact factor: 3.009

2.  DNA and HSA interaction of Vanadium (IV), Copper (II), and Zinc (II) complexes derived from an asymmetric bidentate Schiff-base ligand: multi spectroscopic, viscosity measurements, molecular docking, and ONIOM studies.

Authors:  Monireh Dehkhodaei; Mehdi Sahihi; Hadi Amiri Rudbari; Fariborz Momenbeik
Journal:  J Biol Inorg Chem       Date:  2017-11-08       Impact factor: 3.358

3.  A Novel Detection Method of Human Serum Albumin Based on the Poly(Thymine)-Templated Copper Nanoparticles.

Authors:  Mingjian Chen; Xinying Xiang; Kefeng Wu; Hailun He; Hanchun Chen; Changbei Ma
Journal:  Sensors (Basel)       Date:  2017-11-21       Impact factor: 3.576

4.  Structural Analysis, Molecular Modelling and Preliminary Competition Binding Studies of AM-DAN as a NMDA Receptor PCP-Site Fluorescent Ligand.

Authors:  Sethu Ndzibongwana; Samukelo Ngobese; Ahmad Sayed; Ciniso Shongwe; Simon White-Phillips; Jacques Joubert
Journal:  Molecules       Date:  2019-11-13       Impact factor: 4.411

Review 5.  Protein Binding in Translational Antimicrobial Development-Focus on Interspecies Differences.

Authors:  Hifza Ahmed; Felix Bergmann; Markus Zeitlinger
Journal:  Antibiotics (Basel)       Date:  2022-07-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.